Search
Close this search box.
Logo Asphalion

NEW! | The 3rd eAF-PMS Newsletter has been published on the EMA website!

This 3rd edition of the eAF-PMS Newsletter highlights the latest news, upcoming events and activities planned for the next months. An updated timeline of the web-based Human Variations electronic application form (eAF) accessible from the Product Lifecycle Management (PLM) Portal is now available to all interested stakeholders. The timeline highlights important milestones to be achieved in the upcoming months with regards to the release of new functionalities, User Acceptance Testing (UAT) and start of the transition period. A version of the timeline highlighting impacts on the eAF users in the different periods is also available for consultation. If you are interested in the progress of

This 3rd edition of the eAF-PMS Newsletter highlights the latest news, upcoming events and activities planned for the next months. An updated timeline of the web-based Human Variations electronic application form (eAF) accessible from the Product Lifecycle Management (PLM) Portal is now available to all interested stakeholders. The timeline highlights important milestones to be achieved in the upcoming months with regards to the release of new functionalities, User Acceptance Testing (UAT) and start of the transition period. A version of the timeline highlighting impacts on the eAF users in the different periods is also available for consultation. If you are interested in the progress of
May 18, 2023

The eAF newsletter is published four times a year and provides pharmaceutical companies and the national competent authorities in the EU with updates on the progress of the web-based eAF and PMS.

This third issue covers topics such as:

  • Human Variation eAF updated timeline
  • National IDMP implementation strategies and FHIR through UNICOM
  • PMS news
  • eAF-PMS events

 

You can find the complete third issue of the newsletter here.

For further information, contact us at: info@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

VIDEO | IDMP pills

Welcome to Asphalion’s IDMP pills! Over the next weeks, we will be sharing short videos explaining specific Data Management concepts. Check out the first video

CTIS applicable | Faster Access to Clinical Trial Information in Europe

CTIS is the single-entry point for the submission and assessment of clinical trial applications in the EU. It features a public, searchable database aimed at delivering a high level of transparency. The authorisation and oversight of clinical trials are managed by EU/EEA Member States, while the EMA maintains the CTIS. The European Commission oversees the implementation of the Clinical Trials Regulation.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting